Valeant (VRX), DepoMed (DEPO) Sue Watson (WPI) Over Generic Glumetza
Bloomberg reporting Valent Pharma (NYSE: VRX) and DepoMed (Nasdaq: DEPO) have sued Watson (NYSE: WPI), challenging the company's generic glumetza product.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sequenom (SQNM) Disappointed Supreme Court Denied Petition Requesting Review of Decision on '540 Patent
- PPG Industries (PPG) Announces Plans to Transfer $1.6B of Pension Obligations
- Gannett (GCI) Enters Agreement to Acquire ReachLocal (RLOC) for $4.60/Share in Cash
Create E-mail Alert Related CategoriesCorporate News, Litigation
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!